3 Reasons Aphria (TSX:APHA) Could Beat Aurora Cannabis (TSX:ACB) in Europe

While the battle among Canadian marijuana producers for Europe market dominance continues to shape up in 2020, clear winners are emerging judging from recent licensing developments, capacity analysis and related strategic moves from the respective challengers.  Aurora Cannabis (TSX:ACB)(NYSE:ACB) and Canopy Growth have enjoyed some first mover advantage after reporting some significant sales run rates in Germany over the past…

Read More

Why the Aphria (APHA) Stock Price Fell 8.7% in January

Cannabis stocks have certainly taken a beating in the last year. For some, this beating continues into 2020. Aphria Inc. (TSX:APHA)(NYSE:APHA) stock price fell once again in January, as other cannabis stocks have benefitted from investors seeking a bargain in this potentially lucrative industry. From Aphria stock target price raises to EU certification to analyst upgrades, recent Aphria stock news…

Read More

Cannabis May Not Rebound in 2020, but Aphria (TSX:APHA) Could Soar

Many pundits are predicting that after a rough 2019, cannabis stocks will bounce back in 2020. During 2019, the marijuana bubble burst, seeing many cannabis stocks plunge sharply over the course of the year, causing the industry’s largest exchange-traded fund (ETF), ETFMG Alternative Harvest ETF, to lose a whopping 35%, with its largest single holding Canopy Growth shedding the same…

Read More

TFSA Investors: Buy Aphria (TSX:APHA) Stock

Cannabis grower and leading distributor Aphria’s (TSX:APHA)(NYSE:APHA) stock price could continue to surge and outperform industry peers in 2020, and I’m maintaining my positive outlook and reiterating a buy recommendation on this marijuana firm. In a November 2019 post, and while discussing three potential buys for 2020, I likened the stock’s potential payoff to that on a cannabis lottery ticket.…

Read More

Marijuana Investors: 2 Powerful Trends to Track in 2020

The marijuana boom was supposed to happen last year. Investors expected the likes of Canopy Growth, Aphria, and Aurora Cannabis (TSX:ACB)(NYSE:ACB) to reach stratospheric heights in prosperity. Instead, the legal marijuana sector faced an enormously challenging year. Canadian investors saw both big and small names in the industry struggle. The three major cannabis producers tanked to devastating lows after climbing to…

Read More

Will Aphria (TSX:APHA) Stock Hit Double Digits This Winter?

Aphria (TSX:APHA)(NYSE:APHA) stock is currently trading around $7, far from its 52-week high of $14.37, which was reached on February 4, 2019. The last time Aphria’s share price was in the double digits was on August 6, when the stock traded at a high of $10.05. Like other cannabis stocks, Aphria stock fell in 2019, plunging 11% over the year.…

Read More

4 Must-Know Developments in Aphria’s (TSX:APHA) Q2 2020 Earnings Report

Canadian marijuana producer Aphria (TSX:APHA)(NYSE:APHA) released its fiscal second-quarter 2020 results for the period ended November 30, 2019, on Tuesday in a report in which management stressed strong consumer cannabis revenue growth and three quarters of positive EBITDA, but there is a lot more to chew when one closely examines the numbers. Here are some takeaways from the company’s latest…

Read More

This 1 Marijuana Stock Has the Highest Chance to Recover in 2020

The fun industry of recreational marijuana didn’t have any fun in the stock market last year. The most influential players in the game were beaten to the ground. Aurora Cannabis, one of the largest marijuana companies, went down 59% in market value. Even Canopy Growth, the company with the most robust balance sheet, went down by 25%. But the dark…

Read More

Will Aphria’s (TSX:APHA) Stock Tank if Q2 Earnings Miss?

Aphria (TSX:APHA)(NYSE:APHA) was one of the better-performing cannabis stocks of 2019. Although its stock declined in value for the year, it fell less than most of its peers thanks to two consecutive quarters of positive net income. Aphria’s positive earnings results in 2019 were a surprise to most investors. Cannabis stocks had broadly been expected to lose money, and few expected…

Read More